Skip to Content


In the US, Deferasirox (deferasirox systemic) is a member of the drug class chelating agents and is used to treat Hemochromatosis, Hemosiderosis, Iron Overload and Thalassemia.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Iron chelator

Chemical Names

4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl}benzoesäure (IUPAC)

4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl}benzoic acid (WHO)

Foreign Names

  • Deferasiroxum (Latin)
  • Deferasirox (German)
  • Deferasirox (French)
  • Deferasirox (Spanish)

Generic Names

  • Deferasirox (OS: USAN, JAN)
  • CGP-72670 (IS: Novartis)
  • ICL 670 (IS)
  • ICL-670A (IS: Novartis)

Brand Names

  • Exjade
    Grupo Novartis, Spain; Haemato Pharm, Austria; Novartis, Argentina; Novartis, Bosnia & Herzegowina; Novartis, Belgium; Novartis, Brazil; Novartis, Chile; Novartis, China; Novartis, Czech Republic; Novartis, Denmark; Novartis, Ecuador; Novartis, Egypt; Novartis, Finland; Novartis, France; Novartis, Georgia; Novartis, Greece; Novartis, Hong Kong; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, South Korea; Novartis, Lebanon; Novartis, Lithuania; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Serbia; Novartis, Sweden; Novartis, Slovakia; Novartis, Thailand; Novartis, Tunisia; Novartis, Turkey; Novartis, Taiwan; Novartis, United States; Novartis AH, South Africa; Novartis Europharm, Austria; Novartis Europharm, Cyprus; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Healthcare, Philippines; Novartis Pharma, Switzerland; Novartis Pharma, Russian Federation; Novartis Pharma, Vietnam; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom
    Novartis Pharma, Germany


IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.